data_1bsn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bsn _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 109.42 -0.585 . . . . 4.6299999999999999 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 32.2 mtm -149.18 18.06 0.96 Allowed 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.452 -0.78 . . . . 4.8700000000000001 111.073 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 p -121.08 130.28 53.69 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.794 -1.191 . . . . 2.4500000000000002 109.676 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -130.31 -176.78 4.06 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.444 -0.785 . . . . 2.3300000000000001 110.544 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -116.95 127.4 54.18 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.269 -0.894 . . . . 2.2799999999999998 109.544 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.663 HD21 HG12 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -126.62 139.14 53.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.097 -1.002 . . . . 1.76 110.144 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.28 120.82 34.23 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.537 0.684 . . . . 1.8200000000000001 109.644 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.548 ' HA ' HG21 ' A' ' 78' ' ' VAL . 2.6 p -128.71 107.99 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.729 0.776 . . . . 1.6899999999999999 109.721 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.43 146.9 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.348 -0.845 . . . . 2.1800000000000002 110.133 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.622 ' CB ' ' HB1' ' A' ' 83' ' ' ALA . 3.9 m -123.3 124.88 43.96 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.115 -0.698 . . . . 2.29 109.115 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 52.01 -97.68 0.06 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.877 -0.514 . . . . 3.0 109.809 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.91 67.73 1.51 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.012 -1.055 . . . . 4.4400000000000004 110.161 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -160.4 155.19 24.14 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.578 -1.326 . . . . 6.0300000000000002 111.822 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -103.78 107.95 19.04 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.846 -0.534 . . . . 4.8499999999999996 110.39 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.656 ' HB3' HG22 ' A' ' 62' ' ' ILE . 9.5 mtp -88.66 -47.0 8.58 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.218 -0.926 . . . . 1.8600000000000001 108.928 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.454 ' HB3' HG11 ' A' ' 8' ' ' VAL . 27.0 t80 -159.3 117.54 2.83 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.223 -1.029 . . . . 2.29 108.223 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.9 p -144.18 91.47 2.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.547 -0.721 . . . . 1.48 110.157 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.63 -149.18 12.24 Favored Glycine 0 N--CA 1.504 3.197 0 C-N-CA 120.083 -1.056 . . . . 1.3300000000000001 111.173 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.1 mt -79.94 139.89 36.89 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.633 -0.922 . . . . 2.52 110.7 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.663 HG12 HD21 ' A' ' 6' ' ' LEU . 1.7 p -147.15 152.57 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.362 -0.836 . . . . 1.49 110.647 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' OE2' ' HE2' ' A' ' 22' ' ' LYS . 1.6 tt0 -100.22 -51.17 3.73 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.393 -0.817 . . . . 2.2400000000000002 109.771 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.549 ' HE2' ' OE2' ' A' ' 21' ' ' GLU . 9.1 ttpt -155.13 135.34 13.13 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.357 -0.84 . . . . 3.5600000000000001 110.959 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.572 HG21 HG21 ' A' ' 52' ' ' ILE . 34.2 pt -122.76 134.19 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.141 -0.974 . . . . 2.3599999999999999 109.425 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -112.64 116.58 30.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.312 -0.868 . . . . 2.96 109.65 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -101.43 125.49 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.76 -0.587 . . . . 2.3500000000000001 109.974 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.4 m -120.59 106.61 11.93 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.375 -0.828 . . . . 1.96 109.56 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.55 -77.66 0.24 Allowed Glycine 0 N--CA 1.501 2.989 0 N-CA-C 110.064 -1.214 . . . . 2.1299999999999999 110.064 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.8 t -157.35 -61.77 0.09 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.443 -1.033 . . . . 3.5299999999999998 110.362 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -95.49 99.68 11.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.19 -0.944 . . . . 3.8700000000000001 110.744 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.75 100.87 1.59 Allowed Glycine 0 N--CA 1.503 3.104 0 N-CA-C 111.012 -0.835 . . . . 2.6299999999999999 111.012 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -87.84 50.63 2.03 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.64 -0.918 . . . . 3.23 109.467 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.407 HD21 ' HA ' ' A' ' 32' ' ' LEU . 36.2 mt -123.98 151.42 43.67 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.987 -1.071 . . . . 2.2799999999999998 109.831 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.413 ' C ' HG12 ' A' ' 34' ' ' ILE . . . -117.68 -105.57 2.32 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.112 -1.195 . . . . 1.4299999999999999 110.112 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.478 ' HB ' HG12 ' A' ' 23' ' ' ILE . 19.8 mm -150.02 148.68 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.781 -0.835 . . . . 1.74 109.769 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.648 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -155.12 174.23 4.1 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 121.707 -0.62 . . . . 3.21 109.497 179.442 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.648 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 33.3 Cg_endo -71.04 83.77 0.91 Allowed 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 122.46 2.107 . . . . 1.8200000000000001 110.372 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.52 45.6 0.26 Allowed Glycine 0 N--CA 1.5 2.947 0 N-CA-C 109.353 -1.499 . . . . 1.76 109.353 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -94.16 161.33 14.31 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.646 -0.914 . . . . 3.1000000000000001 110.032 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.439 ' HB2' ' HD2' ' A' ' 40' ' ' PRO . . . -72.03 161.2 80.1 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.243 -0.911 . . . . 2.7000000000000002 110.211 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.587 ' HA ' ' CG1' ' A' ' 71' ' ' VAL . 32.8 Cg_endo -73.37 78.58 2.29 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.555 2.17 . . . . 2.4199999999999999 110.404 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.06 123.87 33.19 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.417 -0.802 . . . . 3.25 110.564 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.8 mt -131.36 63.63 1.6 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.333 -0.988 . . . . 2.8900000000000001 108.333 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.4 p -137.24 -150.38 0.35 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.351 -0.843 . . . . 2.9900000000000002 110.329 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.09 135.17 42.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 2.0699999999999998 111.209 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.623 HG13 ' HB3' ' A' ' 69' ' ' LEU . 4.2 mt -69.58 153.13 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.507 -0.923 . . . . 3.1400000000000001 108.507 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.526 ' HD2' ' N ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -87.89 140.42 31.15 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.966 . . . . 5.1600000000000001 109.527 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.464 ' HB3' ' C ' ' A' ' 65' ' ' SER . 31.6 Cg_endo -71.32 131.57 19.29 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.452 2.101 . . . . 2.29 111.008 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 160.79 -146.55 12.57 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.069 -1.212 . . . . 1.0700000000000001 110.069 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.1 ptm -113.84 147.88 37.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.341 -1.094 . . . . 1.6399999999999999 110.165 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 50' ' ' ILE . 2.6 tt -130.04 130.85 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.312 -0.868 . . . . 1.8700000000000001 110.857 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -99.1 126.33 44.82 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.68 -1.229 . . . . 3.5600000000000001 107.68 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.572 HG21 HG21 ' A' ' 23' ' ' ILE . 74.9 mt -119.25 117.73 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.138 -0.976 . . . . 2.23 111.752 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.5 t -83.18 111.71 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.92 -1.141 . . . . 1.8100000000000001 107.92 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -59.95 148.61 34.55 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.447 -0.783 . . . . 4.8200000000000003 109.965 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.66 -34.6 8.27 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.657 -0.652 . . . . 6.3300000000000001 109.925 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -168.7 134.7 1.78 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.187 -0.672 . . . . 8.0 109.187 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.63 -101.43 0.57 Allowed Glycine 0 N--CA 1.503 3.142 0 N-CA-C 108.546 -1.822 . . . . 3.3700000000000001 108.546 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -133.46 -172.19 2.89 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 121.47 -1.018 . . . . 4.29 109.176 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -122.71 160.71 25.31 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.823 -1.173 . . . . 2.6899999999999999 110.027 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.61 163.31 28.36 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.341 -0.849 . . . . 2.73 111.2 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.437 ' CD1' ' N ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -128.44 120.33 26.67 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.486 -0.759 . . . . 2.6200000000000001 109.317 -179.61 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.656 HG22 ' HB3' ' A' ' 15' ' ' MET . 14.2 mt -116.91 161.33 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 121.377 -0.827 . . . . 2.0099999999999998 111.159 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.513 ' HD1' ' HB ' ' A' ' 84' ' ' ILE . 9.9 t80 -131.37 139.98 49.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.515 -0.741 . . . . 2.4399999999999999 109.473 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.31 141.79 26.46 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.055 -0.72 . . . . 2.23 109.055 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.655 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 0.5 OUTLIER -92.43 36.71 1.0 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.157 -0.964 . . . . 2.3399999999999999 110.953 -179.049 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.7 155.89 11.77 Favored Glycine 0 N--CA 1.506 3.319 0 O-C-N 121.066 -1.021 . . . . 1.8400000000000001 111.286 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 169.02 171.95 35.28 Favored Glycine 0 N--CA 1.506 3.326 0 N-CA-C 110.227 -1.149 . . . . 1.54 110.227 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 83.7 mt -98.94 143.14 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.166 -1.196 . . . . 2.6400000000000001 109.67 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.623 ' HB3' HG13 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -136.49 149.06 47.98 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.195 -0.941 . . . . 3.0 110.428 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' O ' HG21 ' A' ' 76' ' ' VAL . 6.0 pt-20 -136.29 137.68 40.96 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.316 0.579 . . . . 2.3700000000000001 110.212 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.587 ' CG1' ' HA ' ' A' ' 40' ' ' PRO . 1.7 p -101.7 138.98 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.077 -1.015 . . . . 1.8700000000000001 109.953 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.704 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 68.3 mt-30 -122.84 171.22 6.86 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.504 -0.747 . . . . 2.48 109.581 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.704 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 33.7 Cg_endo -74.39 70.73 4.73 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.188 1.925 . . . . 1.76 110.919 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.59 -23.71 4.21 Favored Glycine 0 N--CA 1.504 3.188 0 N-CA-C 110.547 -1.021 . . . . 1.28 110.547 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 1.2 p30 -142.1 170.15 16.25 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.293 -1.122 . . . . 2.2200000000000002 110.95 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.61 HG11 ' HB2' ' A' ' 6' ' ' LEU . 2.3 p -145.84 130.92 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 121.357 -0.839 . . . . 2.1800000000000002 109.042 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.5 143.53 45.18 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.347 -0.846 . . . . 2.02 110.597 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -139.38 142.93 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.187 -0.946 . . . . 1.9299999999999999 109.666 179.091 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.89 123.73 35.72 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.453 -0.78 . . . . 2.54 109.741 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 10' ' ' SER . . . -133.9 -177.59 4.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.532 -0.73 . . . . 1.47 110.5 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 10' ' ' SER . 4.6 m-20 -114.29 -78.2 0.58 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.281 -0.887 . . . . 2.6099999999999999 110.356 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.655 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 69.6 m -64.75 102.6 0.6 Allowed 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.089 -1.007 . . . . 2.0099999999999998 109.282 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.622 ' HB1' ' CB ' ' A' ' 10' ' ' SER . . . -111.45 139.62 46.72 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.809 -0.557 . . . . 1.49 110.569 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.513 ' HB ' ' HD1' ' A' ' 63' ' ' TYR . 96.3 mt -150.86 144.63 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 CA-C-O 121.575 0.702 . . . . 2.1800000000000002 110.639 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.49 167.01 11.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.387 -0.821 . . . . 4.0999999999999996 110.015 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.569 ' HA2' ' CG2' ' A' ' 130' ' ' VAL . . . -56.19 -33.9 61.89 Favored Glycine 0 N--CA 1.508 3.444 0 N-CA-C 109.978 -1.249 . . . . 1.76 109.978 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.49 55.17 1.78 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.05 -1.093 . . . . 3.6499999999999999 108.05 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.1 -65.64 0.53 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.639 -0.663 . . . . 3.3599999999999999 110.814 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.88 -70.55 0.26 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.05 -1.032 . . . . 3.73 110.376 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 0.3 OUTLIER -87.38 130.94 34.46 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.382 -0.824 . . . . 3.25 110.461 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -91.34 -70.7 0.67 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.44 -0.788 . . . . 3.1400000000000001 110.071 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.73 -32.4 67.39 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.351 -0.843 . . . . 2.1000000000000001 111.986 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.545 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 3.4 mtt85 -56.91 -28.9 62.54 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.143 -0.973 . . . . 5.5899999999999999 111.287 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.438 ' HB2' HD11 ' A' ' 128' ' ' LEU . . . -52.85 -35.83 57.97 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.316 -0.865 . . . . 1.5700000000000001 109.798 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 9.8 mtt -69.9 -37.36 75.97 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.449 -0.782 . . . . 2.9399999999999999 110.198 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.507 ' OE2' ' HD2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -57.0 -48.05 79.38 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.448 -0.782 . . . . 3.1000000000000001 109.255 179.2 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.48 -48.22 69.12 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.78 -0.575 . . . . 1.8 109.693 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.431 ' HZ1' ' CD ' ' A' ' 102' ' ' GLU . 12.8 tmtt? -57.81 -51.05 71.19 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.628 -0.67 . . . . 3.0899999999999999 109.537 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.39 -48.38 74.42 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.694 -0.629 . . . . 4.7000000000000002 109.589 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.507 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 9.4 mtpt -64.63 -35.68 81.79 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.719 -0.613 . . . . 4.46 109.831 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.492 ' HB3' ' HG ' ' A' ' 121' ' ' LEU . . . -68.36 -39.95 81.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.444 -0.785 . . . . 1.77 109.386 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.431 ' CD ' ' HZ1' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -51.11 -45.8 61.66 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.572 0.701 . . . . 3.0699999999999998 109.746 179.132 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -52.02 -53.65 39.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.967 -0.458 . . . . 3.9100000000000001 110.474 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -56.17 -32.49 64.37 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.431 -0.793 . . . . 3.6099999999999999 111.55 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 118' ' ' SER . 8.9 mt -94.05 2.92 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 120.901 -1.124 . . . . 2.27 110.567 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.44 -31.97 73.29 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 120.409 -1.432 . . . . 3.4300000000000002 111.116 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 108' ' ' SER . 40.2 t -150.9 161.72 42.16 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.899 -1.125 . . . . 5.3600000000000003 111.517 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 107' ' ' SER . 4.8 t 150.89 176.97 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 108.51 -0.922 . . . . 4.3399999999999999 108.51 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.422 ' N ' ' OG ' ' A' ' 108' ' ' SER . 82.5 m-70 -141.8 -167.67 2.5 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.985 -1.072 . . . . 6.7800000000000002 109.159 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.07 166.09 40.07 Favored Glycine 0 N--CA 1.502 3.058 0 O-C-N 121.012 -1.055 . . . . 4.2199999999999998 110.659 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.62 -64.04 1.22 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.871 -0.782 . . . . 4.8499999999999996 110.28 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.4 m -97.39 28.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 121.0 -1.062 . . . . 3.8599999999999999 111.19 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -87.87 -98.82 0.08 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.838 -1.164 . . . . 4.1799999999999997 108.688 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.48 ' HB3' ' OG ' ' A' ' 108' ' ' SER . 0.1 OUTLIER -59.5 -34.57 72.76 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.772 -1.205 . . . . 5.7699999999999996 109.862 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -50.52 -36.15 32.77 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.246 -0.909 . . . . 2.9399999999999999 109.666 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -64.2 -46.46 83.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.847 -0.797 . . . . 4.1100000000000003 108.847 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.24 -29.58 63.91 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.806 -0.559 . . . . 2.73 109.588 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.581 ' HA ' ' CD1' ' A' ' 105' ' ' ILE . 0.3 OUTLIER -55.6 -44.59 77.12 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.367 -0.833 . . . . 2.79 109.13 178.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.69 -39.53 91.8 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.564 -0.902 . . . . 2.2000000000000002 108.564 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -63.59 -43.01 98.22 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.608 -0.886 . . . . 3.23 108.608 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 101' ' ' ALA . 1.5 tt -60.06 -59.26 5.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.712 -0.617 . . . . 3.6699999999999999 109.415 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -50.78 -36.74 38.44 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.709 -0.619 . . . . 1.8400000000000001 109.485 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.51 ' HD2' ' OG ' ' A' ' 65' ' ' SER . 2.0 ttmt -55.93 -47.0 78.33 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.777 -0.577 . . . . 4.21 109.961 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.483 ' O ' ' HG2' ' A' ' 127' ' ' GLN . . . -70.16 -25.58 63.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.675 -0.64 . . . . 1.76 110.165 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.466 HD11 ' O ' ' A' ' 121' ' ' LEU . 1.4 mp -76.4 -25.07 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.164 -0.96 . . . . 1.97 109.95 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -56.51 -48.07 77.99 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.221 -0.924 . . . . 1.6200000000000001 110.413 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 124' ' ' ALA . 20.5 pt20 -62.89 -28.02 69.76 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.16 -0.963 . . . . 2.73 110.379 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -66.61 -24.98 66.39 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.004 -1.06 . . . . 2.2200000000000002 109.942 179.38 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -74.07 -39.33 63.54 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.107 -0.995 . . . . 3.9900000000000002 110.351 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.569 ' CG2' ' HA2' ' A' ' 86' ' ' GLY . 13.2 m -71.28 -39.01 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.345 -0.847 . . . . 1.8200000000000001 110.812 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.421 HG21 ' O ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -63.08 -37.57 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.369 -0.832 . . . . 2.1699999999999999 109.382 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.42 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 35.2 mm-40 -63.89 -40.53 96.73 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.773 -1.204 . . . . 2.2400000000000002 108.635 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.85 -42.19 86.11 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.639 -0.663 . . . . 2.5800000000000001 110.926 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.2 p -54.41 -34.25 60.95 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 120.99 -1.069 . . . . 2.1000000000000001 109.702 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 132' ' ' GLU . 73.1 mttt -54.71 -40.16 68.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.741 -0.599 . . . . 3.46 110.371 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.4 mttm -97.0 36.3 1.44 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.6 -0.687 . . . . 4.46 110.386 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -140.09 54.13 1.65 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.244 -0.91 . . . . 3.2799999999999998 109.337 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 10.6 mtp . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 117.787 -1.101 . . . . 5.3200000000000003 110.643 -179.529 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 109.42 -0.585 . . . . 4.24 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 32.2 mtm -149.18 18.06 0.96 Allowed 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.452 -0.78 . . . . 4.48 111.073 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 p -121.08 130.28 53.69 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.794 -1.191 . . . . 2.11 109.676 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -130.31 -176.78 4.06 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.444 -0.785 . . . . 1.52 110.544 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.449 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -116.95 127.4 54.18 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.269 -0.894 . . . . 1.53 109.544 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.781 ' HB2' HG13 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -126.62 139.14 53.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.097 -1.002 . . . . 1.1 110.144 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.491 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -123.28 120.82 34.23 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.537 0.684 . . . . 1.82 109.644 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.702 HG23 ' CG2' ' A' ' 78' ' ' VAL . 2.6 p -128.71 107.99 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.729 0.776 . . . . 1.19 109.721 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 14' ' ' GLN . 3.7 m -124.43 146.9 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.348 -0.845 . . . . 1.7 110.133 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.962 ' CB ' ' HB2' ' A' ' 83' ' ' ALA . 3.9 m -123.3 124.88 43.96 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.115 -0.698 . . . . 2.29 109.115 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 52.01 -97.68 0.06 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.877 -0.514 . . . . 2.77 109.809 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.91 67.73 1.51 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.012 -1.055 . . . . 4.44 110.161 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -160.4 155.19 24.14 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.578 -1.326 . . . . 5.33 111.822 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.475 ' HA ' HG12 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -103.78 107.95 19.04 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.846 -0.534 . . . . 4.17 110.39 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.99 ' HE3' ' HB1' ' A' ' 83' ' ' ALA . 9.5 mtp -88.66 -47.0 8.58 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.218 -0.926 . . . . 1.86 108.928 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.481 ' HB3' HG12 ' A' ' 8' ' ' VAL . 27.0 t80 -159.3 117.54 2.83 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.223 -1.029 . . . . 1.47 108.223 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.9 p -144.18 91.47 2.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.547 -0.721 . . . . 1.21 110.157 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.63 -149.18 12.24 Favored Glycine 0 N--CA 1.504 3.197 0 C-N-CA 120.083 -1.056 . . . . 1.21 111.173 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.1 mt -79.94 139.89 36.89 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.633 -0.922 . . . . 2.05 110.7 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.71 HG11 HD23 ' A' ' 6' ' ' LEU . 1.7 p -147.15 152.57 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.362 -0.836 . . . . 1.15 110.647 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.563 ' OE2' ' HE2' ' A' ' 22' ' ' LYS . 1.6 tt0 -100.22 -51.17 3.73 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.393 -0.817 . . . . 2.24 109.771 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.563 ' HE2' ' OE2' ' A' ' 21' ' ' GLU . 9.1 ttpt -155.13 135.34 13.13 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.357 -0.84 . . . . 3.2 110.959 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.059 HG22 HG23 ' A' ' 52' ' ' ILE . 34.2 pt -122.76 134.19 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.141 -0.974 . . . . 1.8 109.425 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -112.64 116.58 30.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.312 -0.868 . . . . 2.52 109.65 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.671 HG22 HD12 ' A' ' 50' ' ' ILE . 47.5 t -101.43 125.49 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.76 -0.587 . . . . 1.72 109.974 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.4 m -120.59 106.61 11.93 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.375 -0.828 . . . . 1.42 109.56 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.55 -77.66 0.24 Allowed Glycine 0 N--CA 1.501 2.989 0 N-CA-C 110.064 -1.214 . . . . 2.13 110.064 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.8 t -157.35 -61.77 0.09 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.443 -1.033 . . . . 3.19 110.362 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -95.49 99.68 11.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.19 -0.944 . . . . 3.87 110.744 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.75 100.87 1.59 Allowed Glycine 0 N--CA 1.503 3.104 0 N-CA-C 111.012 -0.835 . . . . 2.3 111.012 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -87.84 50.63 2.03 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.64 -0.918 . . . . 3.23 109.467 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 32' ' ' LEU . 36.2 mt -123.98 151.42 43.67 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.987 -1.071 . . . . 1.91 109.831 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.406 ' C ' HG12 ' A' ' 34' ' ' ILE . . . -117.68 -105.57 2.32 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.112 -1.195 . . . . 1.34 110.112 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.724 HG21 HG11 ' A' ' 76' ' ' VAL . 19.8 mm -150.02 148.68 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.781 -0.835 . . . . 1.3 109.769 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.673 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -155.12 174.23 4.1 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 121.707 -0.62 . . . . 2.64 109.497 179.442 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.673 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 33.3 Cg_endo -71.04 83.77 0.91 Allowed 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 122.46 2.107 . . . . 1.82 110.372 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.52 45.6 0.26 Allowed Glycine 0 N--CA 1.5 2.947 0 N-CA-C 109.353 -1.499 . . . . 1.69 109.353 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -94.16 161.33 14.31 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.646 -0.914 . . . . 2.34 110.032 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.55 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -72.03 161.2 80.1 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.243 -0.911 . . . . 2.3 110.211 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' HA ' ' CG1' ' A' ' 71' ' ' VAL . 32.8 Cg_endo -73.37 78.58 2.29 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.555 2.17 . . . . 2.2 110.404 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.472 ' HA ' HD13 ' A' ' 41' ' ' LEU . 2.6 mm? -88.06 123.87 33.19 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.417 -0.802 . . . . 2.86 110.564 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.8 mt -131.36 63.63 1.6 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.333 -0.988 . . . . 2.41 108.333 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.4 p -137.24 -150.38 0.35 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.351 -0.843 . . . . 2.56 110.329 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.09 135.17 42.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 1.6 111.209 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.633 HG13 ' HB3' ' A' ' 69' ' ' LEU . 4.2 mt -69.58 153.13 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.507 -0.923 . . . . 2.6 108.507 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -87.89 140.42 31.15 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.966 . . . . 4.87 109.527 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.481 ' HB3' ' C ' ' A' ' 65' ' ' SER . 31.6 Cg_endo -71.32 131.57 19.29 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.452 2.101 . . . . 2.01 111.008 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 160.79 -146.55 12.57 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.069 -1.212 . . . . 0.99 110.069 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.1 ptm -113.84 147.88 37.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.341 -1.094 . . . . 1.49 110.165 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.671 HD12 HG22 ' A' ' 25' ' ' VAL . 2.6 tt -130.04 130.85 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.312 -0.868 . . . . 1.38 110.857 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -99.1 126.33 44.82 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.68 -1.229 . . . . 3.06 107.68 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.059 HG23 HG22 ' A' ' 23' ' ' ILE . 74.9 mt -119.25 117.73 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.138 -0.976 . . . . 1.61 111.752 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.5 t -83.18 111.71 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.92 -1.141 . . . . 1.39 107.92 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -59.95 148.61 34.55 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.447 -0.783 . . . . 4.37 109.965 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.66 -34.6 8.27 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.657 -0.652 . . . . 5.73 109.925 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -168.7 134.7 1.78 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.187 -0.672 . . . . 7.19 109.187 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.63 -101.43 0.57 Allowed Glycine 0 N--CA 1.503 3.142 0 N-CA-C 108.546 -1.822 . . . . 3.03 108.546 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -133.46 -172.19 2.89 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 121.47 -1.018 . . . . 3.54 109.176 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -122.71 160.71 25.31 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.823 -1.173 . . . . 2.69 110.027 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.61 163.31 28.36 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.341 -0.849 . . . . 2.73 111.2 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.437 ' CD1' ' N ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -128.44 120.33 26.67 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.486 -0.759 . . . . 1.77 109.317 -179.61 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.508 HG21 ' HB3' ' A' ' 15' ' ' MET . 14.2 mt -116.91 161.33 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 121.377 -0.827 . . . . 1.41 111.159 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.52 ' HD1' ' HB ' ' A' ' 84' ' ' ILE . 9.9 t80 -131.37 139.98 49.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.515 -0.741 . . . . 1.62 109.473 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.31 141.79 26.46 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.055 -0.72 . . . . 1.63 109.055 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.686 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 0.5 OUTLIER -92.43 36.71 1.0 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.157 -0.964 . . . . 2.03 110.953 -179.049 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.425 ' O ' ' HB1' ' A' ' 80' ' ' ALA . . . 113.7 155.89 11.77 Favored Glycine 0 N--CA 1.506 3.319 0 O-C-N 121.066 -1.021 . . . . 1.79 111.286 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 169.02 171.95 35.28 Favored Glycine 0 N--CA 1.506 3.326 0 N-CA-C 110.227 -1.149 . . . . 1.33 110.227 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 83.7 mt -98.94 143.14 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.166 -1.196 . . . . 2.2 109.67 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.633 ' HB3' HG13 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -136.49 149.06 47.98 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.195 -0.941 . . . . 2.52 110.428 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 6.0 pt-20 -136.29 137.68 40.96 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.316 0.579 . . . . 2.37 110.212 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.608 ' CG1' ' HA ' ' A' ' 40' ' ' PRO . 1.7 p -101.7 138.98 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.077 -1.015 . . . . 1.42 109.953 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.716 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 68.3 mt-30 -122.84 171.22 6.86 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.504 -0.747 . . . . 2.18 109.581 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.716 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 33.7 Cg_endo -74.39 70.73 4.73 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.188 1.925 . . . . 1.61 110.919 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.59 -23.71 4.21 Favored Glycine 0 N--CA 1.504 3.188 0 N-CA-C 110.547 -1.021 . . . . 1.16 110.547 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 1.2 p30 -142.1 170.15 16.25 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.293 -1.122 . . . . 2.17 110.95 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.781 HG13 ' HB2' ' A' ' 6' ' ' LEU . 2.3 p -145.84 130.92 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 121.357 -0.839 . . . . 1.54 109.042 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.5 143.53 45.18 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.347 -0.846 . . . . 1.44 110.597 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.702 ' CG2' HG23 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -139.38 142.93 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.187 -0.946 . . . . 1.32 109.666 179.091 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.89 123.73 35.72 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.453 -0.78 . . . . 2.1 109.741 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 10' ' ' SER . . . -133.9 -177.59 4.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.532 -0.73 . . . . 1.34 110.5 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 10' ' ' SER . 4.6 m-20 -114.29 -78.2 0.58 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.281 -0.887 . . . . 2.61 110.356 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.686 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 69.6 m -64.75 102.6 0.6 Allowed 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.089 -1.007 . . . . 1.56 109.282 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.99 ' HB1' ' HE3' ' A' ' 15' ' ' MET . . . -111.45 139.62 46.72 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.809 -0.557 . . . . 1.2 110.569 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.52 ' HB ' ' HD1' ' A' ' 63' ' ' TYR . 96.3 mt -150.86 144.63 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 CA-C-O 121.575 0.702 . . . . 1.85 110.639 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.49 167.01 11.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.387 -0.821 . . . . 3.59 110.015 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.591 ' HA2' ' CG2' ' A' ' 130' ' ' VAL . . . -56.19 -33.9 61.89 Favored Glycine 0 N--CA 1.508 3.444 0 N-CA-C 109.978 -1.249 . . . . 1.76 109.978 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.625 ' HG2' HG21 ' A' ' 134' ' ' THR . 0.0 OUTLIER -129.49 55.17 1.78 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.05 -1.093 . . . . 3.17 108.05 178.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.1 -65.64 0.53 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.639 -0.663 . . . . 3.36 110.814 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.88 -70.55 0.26 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.05 -1.032 . . . . 3.34 110.376 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 0.3 OUTLIER -87.38 130.94 34.46 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.382 -0.824 . . . . 3.25 110.461 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.47 ' CB ' HD11 ' A' ' 131' ' ' ILE . 11.1 mt-10 -91.34 -70.7 0.67 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.44 -0.788 . . . . 3.14 110.071 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.73 -32.4 67.39 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.351 -0.843 . . . . 1.67 111.986 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.567 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 3.4 mtt85 -56.91 -28.9 62.54 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.143 -0.973 . . . . 4.92 111.287 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.608 ' HB1' HD12 ' A' ' 128' ' ' LEU . . . -52.85 -35.83 57.97 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.316 -0.865 . . . . 1.21 109.798 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 9.8 mtt -69.9 -37.36 75.97 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.449 -0.782 . . . . 2.44 110.198 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.5 ' OE2' ' HD2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -57.0 -48.05 79.38 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.448 -0.782 . . . . 3.1 109.255 179.2 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.48 -48.22 69.12 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.78 -0.575 . . . . 1.44 109.693 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -57.81 -51.05 71.19 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.628 -0.67 . . . . 2.65 109.537 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.39 -48.38 74.42 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.694 -0.629 . . . . 4.14 109.589 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.5 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 9.4 mtpt -64.63 -35.68 81.79 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.719 -0.613 . . . . 4.13 109.831 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.778 ' HB1' ' HG ' ' A' ' 121' ' ' LEU . . . -68.36 -39.95 81.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.444 -0.785 . . . . 1.53 109.386 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.11 -45.8 61.66 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.572 0.701 . . . . 3.07 109.746 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -52.02 -53.65 39.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.967 -0.458 . . . . 3.91 110.474 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -56.17 -32.49 64.37 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.431 -0.793 . . . . 3.24 111.55 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.768 HD12 ' CD1' ' A' ' 121' ' ' LEU . 8.9 mt -94.05 2.92 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 120.901 -1.124 . . . . 2.13 110.567 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.44 -31.97 73.29 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 120.409 -1.432 . . . . 3.35 111.116 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 108' ' ' SER . 40.2 t -150.9 161.72 42.16 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.899 -1.125 . . . . 5.03 111.517 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 114' ' ' TYR . 4.8 t 150.89 176.97 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 108.51 -0.922 . . . . 4.07 108.51 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.422 ' N ' ' OG ' ' A' ' 108' ' ' SER . 82.5 m-70 -141.8 -167.67 2.5 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.985 -1.072 . . . . 6.15 109.159 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.07 166.09 40.07 Favored Glycine 0 N--CA 1.502 3.058 0 O-C-N 121.012 -1.055 . . . . 3.83 110.659 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.62 -64.04 1.22 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.871 -0.782 . . . . 4.85 110.28 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.405 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 21.4 m -97.39 28.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 121.0 -1.062 . . . . 3.52 111.19 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -87.87 -98.82 0.08 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.838 -1.164 . . . . 4.18 108.688 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.72 ' CE1' HG23 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -59.5 -34.57 72.76 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.772 -1.205 . . . . 5.33 109.862 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -50.52 -36.15 32.77 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.246 -0.909 . . . . 2.47 109.666 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 112' ' ' VAL . 1.4 mt-30 -64.2 -46.46 83.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.847 -0.797 . . . . 3.57 108.847 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.24 -29.58 63.91 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.806 -0.559 . . . . 2.34 109.588 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.752 ' HA ' HD11 ' A' ' 105' ' ' ILE . 0.3 OUTLIER -55.6 -44.59 77.12 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.367 -0.833 . . . . 2.47 109.13 178.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.69 -39.53 91.8 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.564 -0.902 . . . . 1.69 108.564 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -63.59 -43.01 98.22 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.608 -0.886 . . . . 3.23 108.608 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.778 ' HG ' ' HB1' ' A' ' 101' ' ' ALA . 1.5 tt -60.06 -59.26 5.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.712 -0.617 . . . . 3.19 109.415 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -50.78 -36.74 38.44 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.709 -0.619 . . . . 1.37 109.485 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.538 ' HD2' ' OG ' ' A' ' 65' ' ' SER . 2.0 ttmt -55.93 -47.0 78.33 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.777 -0.577 . . . . 3.77 109.961 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 127' ' ' GLN . . . -70.16 -25.58 63.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.675 -0.64 . . . . 1.37 110.165 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.582 HD13 HD23 ' A' ' 121' ' ' LEU . 1.4 mp -76.4 -25.07 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.164 -0.96 . . . . 1.38 109.95 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -56.51 -48.07 77.99 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.221 -0.924 . . . . 1.08 110.413 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 124' ' ' ALA . 20.5 pt20 -62.89 -28.02 69.76 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.16 -0.963 . . . . 2.3 110.379 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.608 HD12 ' HB1' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -66.61 -24.98 66.39 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.004 -1.06 . . . . 1.79 109.942 179.38 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -74.07 -39.33 63.54 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.107 -0.995 . . . . 3.36 110.351 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.591 ' CG2' ' HA2' ' A' ' 86' ' ' GLY . 13.2 m -71.28 -39.01 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.345 -0.847 . . . . 1.31 110.812 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.47 HD11 ' CB ' ' A' ' 91' ' ' GLU . 0.4 OUTLIER -63.08 -37.57 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.369 -0.832 . . . . 1.58 109.382 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 35.2 mm-40 -63.89 -40.53 96.73 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.773 -1.204 . . . . 2.24 108.635 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.85 -42.19 86.11 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.639 -0.663 . . . . 2.04 110.926 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.625 HG21 ' HG2' ' A' ' 87' ' ' GLN . 20.2 p -54.41 -34.25 60.95 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 120.99 -1.069 . . . . 1.92 109.702 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 132' ' ' GLU . 73.1 mttt -54.71 -40.16 68.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.741 -0.599 . . . . 3.09 110.371 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.4 mttm -97.0 36.3 1.44 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.6 -0.687 . . . . 4.06 110.386 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -140.09 54.13 1.65 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.244 -0.91 . . . . 3.28 109.337 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 10.6 mtp . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 117.787 -1.101 . . . . 5.02 110.643 -179.529 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 109.42 -0.585 . . . . 4.24 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 32.2 mtm -149.18 18.06 0.96 Allowed 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.452 -0.78 . . . . 4.48 111.073 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.6 p -121.08 130.28 53.69 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.794 -1.191 . . . . 2.11 109.676 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -130.31 -176.78 4.06 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.444 -0.785 . . . . 1.52 110.544 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.449 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -116.95 127.4 54.18 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.269 -0.894 . . . . 1.53 109.544 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.781 ' HB2' HG13 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -126.62 139.14 53.41 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.097 -1.002 . . . . 1.1 110.144 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.491 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -123.28 120.82 34.23 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.537 0.684 . . . . 1.82 109.644 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.702 HG23 ' CG2' ' A' ' 78' ' ' VAL . 2.6 p -128.71 107.99 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.729 0.776 . . . . 1.19 109.721 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 14' ' ' GLN . 3.7 m -124.43 146.9 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.348 -0.845 . . . . 1.7 110.133 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.962 ' CB ' ' HB2' ' A' ' 83' ' ' ALA . 3.9 m -123.3 124.88 43.96 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.115 -0.698 . . . . 2.29 109.115 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 52.01 -97.68 0.06 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.877 -0.514 . . . . 2.77 109.809 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.91 67.73 1.51 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.012 -1.055 . . . . 4.44 110.161 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -160.4 155.19 24.14 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.578 -1.326 . . . . 5.33 111.822 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.475 ' HA ' HG12 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -103.78 107.95 19.04 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.846 -0.534 . . . . 4.17 110.39 179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.99 ' HE3' ' HB1' ' A' ' 83' ' ' ALA . 9.5 mtp -88.66 -47.0 8.58 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.218 -0.926 . . . . 1.86 108.928 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.481 ' HB3' HG12 ' A' ' 8' ' ' VAL . 27.0 t80 -159.3 117.54 2.83 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.223 -1.029 . . . . 1.47 108.223 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.9 p -144.18 91.47 2.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.547 -0.721 . . . . 1.21 110.157 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.63 -149.18 12.24 Favored Glycine 0 N--CA 1.504 3.197 0 C-N-CA 120.083 -1.056 . . . . 1.21 111.173 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.1 mt -79.94 139.89 36.89 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.633 -0.922 . . . . 2.05 110.7 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.71 HG11 HD23 ' A' ' 6' ' ' LEU . 1.7 p -147.15 152.57 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.362 -0.836 . . . . 1.15 110.647 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.563 ' OE2' ' HE2' ' A' ' 22' ' ' LYS . 1.6 tt0 -100.22 -51.17 3.73 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.393 -0.817 . . . . 2.24 109.771 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.563 ' HE2' ' OE2' ' A' ' 21' ' ' GLU . 9.1 ttpt -155.13 135.34 13.13 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.357 -0.84 . . . . 3.2 110.959 -178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.059 HG22 HG23 ' A' ' 52' ' ' ILE . 34.2 pt -122.76 134.19 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.141 -0.974 . . . . 1.8 109.425 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -112.64 116.58 30.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.312 -0.868 . . . . 2.52 109.65 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.671 HG22 HD12 ' A' ' 50' ' ' ILE . 47.5 t -101.43 125.49 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.76 -0.587 . . . . 1.72 109.974 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.4 m -120.59 106.61 11.93 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.375 -0.828 . . . . 1.42 109.56 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -127.55 -77.66 0.24 Allowed Glycine 0 N--CA 1.501 2.989 0 N-CA-C 110.064 -1.214 . . . . 2.13 110.064 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.8 t -157.35 -61.77 0.09 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.443 -1.033 . . . . 3.19 110.362 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -95.49 99.68 11.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.19 -0.944 . . . . 3.87 110.744 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.75 100.87 1.59 Allowed Glycine 0 N--CA 1.503 3.104 0 N-CA-C 111.012 -0.835 . . . . 2.3 111.012 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -87.84 50.63 2.03 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.64 -0.918 . . . . 3.23 109.467 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 32' ' ' LEU . 36.2 mt -123.98 151.42 43.67 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.987 -1.071 . . . . 1.91 109.831 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.406 ' C ' HG12 ' A' ' 34' ' ' ILE . . . -117.68 -105.57 2.32 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.112 -1.195 . . . . 1.34 110.112 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.724 HG21 HG11 ' A' ' 76' ' ' VAL . 19.8 mm -150.02 148.68 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.781 -0.835 . . . . 1.3 109.769 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.673 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -155.12 174.23 4.1 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 121.707 -0.62 . . . . 2.64 109.497 179.442 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.673 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 33.3 Cg_endo -71.04 83.77 0.91 Allowed 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 122.46 2.107 . . . . 1.82 110.372 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.52 45.6 0.26 Allowed Glycine 0 N--CA 1.5 2.947 0 N-CA-C 109.353 -1.499 . . . . 1.69 109.353 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.4 ' HD2' ' CZ ' ' A' ' 35' ' ' TYR . 36.2 t-80 -94.16 161.33 14.31 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.646 -0.914 . . . . 2.34 110.032 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.55 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -72.03 161.2 80.1 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.243 -0.911 . . . . 2.3 110.211 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' HA ' ' CG1' ' A' ' 71' ' ' VAL . 32.8 Cg_endo -73.37 78.58 2.29 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.555 2.17 . . . . 2.2 110.404 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.472 ' HA ' HD13 ' A' ' 41' ' ' LEU . 2.6 mm? -88.06 123.87 33.19 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.417 -0.802 . . . . 2.86 110.564 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.8 mt -131.36 63.63 1.6 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.333 -0.988 . . . . 2.41 108.333 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.4 p -137.24 -150.38 0.35 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.351 -0.843 . . . . 2.56 110.329 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.09 135.17 42.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 1.6 111.209 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.633 HG13 ' HB3' ' A' ' 69' ' ' LEU . 4.2 mt -69.58 153.13 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.507 -0.923 . . . . 2.6 108.507 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -87.89 140.42 31.15 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.966 . . . . 4.87 109.527 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.481 ' HB3' ' C ' ' A' ' 65' ' ' SER . 31.6 Cg_endo -71.32 131.57 19.29 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.452 2.101 . . . . 2.01 111.008 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 160.79 -146.55 12.57 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.069 -1.212 . . . . 0.99 110.069 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.1 ptm -113.84 147.88 37.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.341 -1.094 . . . . 1.49 110.165 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.671 HD12 HG22 ' A' ' 25' ' ' VAL . 2.6 tt -130.04 130.85 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.312 -0.868 . . . . 1.38 110.857 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -99.1 126.33 44.82 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.68 -1.229 . . . . 3.06 107.68 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.059 HG23 HG22 ' A' ' 23' ' ' ILE . 74.9 mt -119.25 117.73 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.138 -0.976 . . . . 1.61 111.752 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.5 t -83.18 111.71 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.92 -1.141 . . . . 1.39 107.92 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -59.95 148.61 34.55 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.447 -0.783 . . . . 4.37 109.965 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.66 -34.6 8.27 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.657 -0.652 . . . . 5.73 109.925 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -168.7 134.7 1.78 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.187 -0.672 . . . . 7.19 109.187 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.63 -101.43 0.57 Allowed Glycine 0 N--CA 1.503 3.142 0 N-CA-C 108.546 -1.822 . . . . 3.03 108.546 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -133.46 -172.19 2.89 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 121.47 -1.018 . . . . 3.54 109.176 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -122.71 160.71 25.31 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.823 -1.173 . . . . 2.69 110.027 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.61 163.31 28.36 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.341 -0.849 . . . . 2.73 111.2 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.437 ' CD1' ' N ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -128.44 120.33 26.67 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.486 -0.759 . . . . 1.77 109.317 -179.61 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.508 HG21 ' HB3' ' A' ' 15' ' ' MET . 14.2 mt -116.91 161.33 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 O-C-N 121.377 -0.827 . . . . 1.41 111.159 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.52 ' HD1' ' HB ' ' A' ' 84' ' ' ILE . 9.9 t80 -131.37 139.98 49.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.515 -0.741 . . . . 1.62 109.473 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.31 141.79 26.46 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.055 -0.72 . . . . 1.63 109.055 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.686 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 0.5 OUTLIER -92.43 36.71 1.0 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.157 -0.964 . . . . 2.03 110.953 -179.049 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.425 ' O ' ' HB1' ' A' ' 80' ' ' ALA . . . 113.7 155.89 11.77 Favored Glycine 0 N--CA 1.506 3.319 0 O-C-N 121.066 -1.021 . . . . 1.79 111.286 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 169.02 171.95 35.28 Favored Glycine 0 N--CA 1.506 3.326 0 N-CA-C 110.227 -1.149 . . . . 1.33 110.227 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 83.7 mt -98.94 143.14 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.166 -1.196 . . . . 2.2 109.67 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.633 ' HB3' HG13 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -136.49 149.06 47.98 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.195 -0.941 . . . . 2.52 110.428 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 6.0 pt-20 -136.29 137.68 40.96 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.316 0.579 . . . . 2.37 110.212 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.608 ' CG1' ' HA ' ' A' ' 40' ' ' PRO . 1.7 p -101.7 138.98 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.077 -1.015 . . . . 1.42 109.953 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.716 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 68.3 mt-30 -122.84 171.22 6.86 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.504 -0.747 . . . . 2.18 109.581 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.716 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 33.7 Cg_endo -74.39 70.73 4.73 Favored 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 122.188 1.925 . . . . 1.61 110.919 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.59 -23.71 4.21 Favored Glycine 0 N--CA 1.504 3.188 0 N-CA-C 110.547 -1.021 . . . . 1.16 110.547 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 1.2 p30 -142.1 170.15 16.25 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.293 -1.122 . . . . 2.17 110.95 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.781 HG13 ' HB2' ' A' ' 6' ' ' LEU . 2.3 p -145.84 130.92 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 121.357 -0.839 . . . . 1.54 109.042 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.5 143.53 45.18 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.347 -0.846 . . . . 1.44 110.597 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.702 ' CG2' HG23 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -139.38 142.93 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.187 -0.946 . . . . 1.32 109.666 179.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.89 123.73 35.72 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.453 -0.78 . . . . 2.1 109.741 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 10' ' ' SER . . . -133.9 -177.59 4.63 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.532 -0.73 . . . . 1.34 110.5 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 10' ' ' SER . 4.6 m-20 -114.29 -78.2 0.58 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.281 -0.887 . . . . 2.61 110.356 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.686 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 69.6 m -64.75 102.6 0.6 Allowed 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.089 -1.007 . . . . 1.56 109.282 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.99 ' HB1' ' HE3' ' A' ' 15' ' ' MET . . . -111.45 139.62 46.72 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.809 -0.557 . . . . 1.2 110.569 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.52 ' HB ' ' HD1' ' A' ' 63' ' ' TYR . 96.3 mt -150.86 144.63 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 CA-C-O 121.575 0.702 . . . . 1.85 110.639 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.49 167.01 11.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.387 -0.821 . . . . 3.59 110.015 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.591 ' HA2' ' CG2' ' A' ' 130' ' ' VAL . . . -56.19 -33.9 61.89 Favored Glycine 0 N--CA 1.508 3.444 0 N-CA-C 109.978 -1.249 . . . . 1.76 109.978 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.625 ' HG2' HG21 ' A' ' 134' ' ' THR . 0.0 OUTLIER -129.49 55.17 1.78 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.05 -1.093 . . . . 3.17 108.05 178.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.1 -65.64 0.53 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.639 -0.663 . . . . 3.36 110.814 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.88 -70.55 0.26 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.05 -1.032 . . . . 3.34 110.376 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 0.3 OUTLIER -87.38 130.94 34.46 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.382 -0.824 . . . . 3.25 110.461 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.47 ' CB ' HD11 ' A' ' 131' ' ' ILE . 11.1 mt-10 -91.34 -70.7 0.67 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.44 -0.788 . . . . 3.14 110.071 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.73 -32.4 67.39 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.351 -0.843 . . . . 1.67 111.986 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.567 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 3.4 mtt85 -56.91 -28.9 62.54 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.143 -0.973 . . . . 4.92 111.287 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.608 ' HB1' HD12 ' A' ' 128' ' ' LEU . . . -52.85 -35.83 57.97 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.316 -0.865 . . . . 1.21 109.798 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 9.8 mtt -69.9 -37.36 75.97 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.449 -0.782 . . . . 2.44 110.198 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.5 ' OE2' ' HD2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -57.0 -48.05 79.38 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.448 -0.782 . . . . 3.1 109.255 179.2 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.48 -48.22 69.12 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.78 -0.575 . . . . 1.44 109.693 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -57.81 -51.05 71.19 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.628 -0.67 . . . . 2.65 109.537 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.39 -48.38 74.42 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.694 -0.629 . . . . 4.14 109.589 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.5 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 9.4 mtpt -64.63 -35.68 81.79 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.719 -0.613 . . . . 4.13 109.831 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.778 ' HB1' ' HG ' ' A' ' 121' ' ' LEU . . . -68.36 -39.95 81.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.444 -0.785 . . . . 1.53 109.386 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.11 -45.8 61.66 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 121.572 0.701 . . . . 3.07 109.746 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -52.02 -53.65 39.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.967 -0.458 . . . . 3.91 110.474 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -56.17 -32.49 64.37 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.431 -0.793 . . . . 3.24 111.55 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.768 HD12 ' CD1' ' A' ' 121' ' ' LEU . 8.9 mt -94.05 2.92 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 120.901 -1.124 . . . . 2.13 110.567 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.44 -31.97 73.29 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 120.409 -1.432 . . . . 3.35 111.116 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 108' ' ' SER . 40.2 t -150.9 161.72 42.16 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.899 -1.125 . . . . 5.03 111.517 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 114' ' ' TYR . 4.8 t 150.89 176.97 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 108.51 -0.922 . . . . 4.07 108.51 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.422 ' N ' ' OG ' ' A' ' 108' ' ' SER . 82.5 m-70 -141.8 -167.67 2.5 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.985 -1.072 . . . . 6.15 109.159 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.07 166.09 40.07 Favored Glycine 0 N--CA 1.502 3.058 0 O-C-N 121.012 -1.055 . . . . 3.83 110.659 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.62 -64.04 1.22 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.871 -0.782 . . . . 4.85 110.28 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.405 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 21.4 m -97.39 28.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 121.0 -1.062 . . . . 3.52 111.19 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -87.87 -98.82 0.08 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.838 -1.164 . . . . 4.18 108.688 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.72 ' CE1' HG23 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -59.5 -34.57 72.76 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.772 -1.205 . . . . 5.33 109.862 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -50.52 -36.15 32.77 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.246 -0.909 . . . . 2.47 109.666 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 112' ' ' VAL . 1.4 mt-30 -64.2 -46.46 83.8 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.847 -0.797 . . . . 3.57 108.847 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.24 -29.58 63.91 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.806 -0.559 . . . . 2.34 109.588 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.752 ' HA ' HD11 ' A' ' 105' ' ' ILE . 0.3 OUTLIER -55.6 -44.59 77.12 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.367 -0.833 . . . . 2.47 109.13 178.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.69 -39.53 91.8 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.564 -0.902 . . . . 1.69 108.564 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -63.59 -43.01 98.22 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.608 -0.886 . . . . 3.23 108.608 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.778 ' HG ' ' HB1' ' A' ' 101' ' ' ALA . 1.5 tt -60.06 -59.26 5.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.712 -0.617 . . . . 3.19 109.415 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -50.78 -36.74 38.44 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.709 -0.619 . . . . 1.37 109.485 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.538 ' HD2' ' OG ' ' A' ' 65' ' ' SER . 2.0 ttmt -55.93 -47.0 78.33 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.777 -0.577 . . . . 3.77 109.961 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 127' ' ' GLN . . . -70.16 -25.58 63.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.675 -0.64 . . . . 1.37 110.165 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.582 HD13 HD23 ' A' ' 121' ' ' LEU . 1.4 mp -76.4 -25.07 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.164 -0.96 . . . . 1.38 109.95 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -56.51 -48.07 77.99 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.221 -0.924 . . . . 1.08 110.413 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 124' ' ' ALA . 20.5 pt20 -62.89 -28.02 69.76 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.16 -0.963 . . . . 2.3 110.379 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.608 HD12 ' HB1' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -66.61 -24.98 66.39 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.004 -1.06 . . . . 1.79 109.942 179.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -74.07 -39.33 63.54 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.107 -0.995 . . . . 3.36 110.351 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.591 ' CG2' ' HA2' ' A' ' 86' ' ' GLY . 13.2 m -71.28 -39.01 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.345 -0.847 . . . . 1.31 110.812 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.47 HD11 ' CB ' ' A' ' 91' ' ' GLU . 0.4 OUTLIER -63.08 -37.57 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.369 -0.832 . . . . 1.58 109.382 179.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 35.2 mm-40 -63.89 -40.53 96.73 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.773 -1.204 . . . . 2.24 108.635 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.85 -42.19 86.11 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.639 -0.663 . . . . 2.04 110.926 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.625 HG21 ' HG2' ' A' ' 87' ' ' GLN . 20.2 p -54.41 -34.25 60.95 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 120.99 -1.069 . . . . 1.92 109.702 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 132' ' ' GLU . 73.1 mttt -54.71 -40.16 68.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.741 -0.599 . . . . 3.09 110.371 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.4 mttm -97.0 36.3 1.44 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.6 -0.687 . . . . 4.06 110.386 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -140.09 54.13 1.65 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.244 -0.91 . . . . 3.28 109.337 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 10.6 mtp . . . . . 0 N--CA 1.5 2.06 0 CA-C-O 117.787 -1.101 . . . . 5.02 110.643 -179.529 . . . . . . . . 0 0 . 1 stop_ save_